114 filings
IRAN
GSK
GSK Plc
5 Mar 24
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
12:30pm
SD
GSK
GSK Plc
30 May 23
Conflict minerals disclosure
2:24pm
EFFECT
Glaxosmithkline Capital Inc
16 Mar 23
Notice of effectiveness
12:15am
IRAN
GSK
GSK Plc
10 Mar 23
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
11:22am
SD
GSK
GSK Plc
27 May 22
Conflict minerals disclosure
4:04pm
IRAN
c6xxuh69ekg45dwt
8 Mar 22
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1:21pm
UPLOAD
k491i
8 Sep 21
Letter from SEC
12:00am
CORRESP
2ha2 damoz
31 Aug 21
Correspondence with SEC
12:00am
UPLOAD
a384x1
18 Aug 21
Letter from SEC
12:00am
SD
ll2i8
27 May 21
Conflict minerals disclosure
4:11pm
IRAN
k25x8p0s6cdrln0ol
12 Mar 21
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3:44pm
CERT
qswvmgh
7 Oct 20
Certification of approval for exchange listing
10:33am
SD
rrlkfjqi
29 May 20
Conflict minerals disclosure
4:10pm
IRAN
vaeitjzejhcxz 75
6 Mar 20
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
4:10pm
EFFECT
dvek10ukgqmp2cffvb5u
30 Jul 19
Notice of effectiveness
12:15am
SD
difa hkho66
31 May 19
Conflict minerals disclosure
2:04pm
CT ORDER
isnyat
2 May 19
Confidential treatment order
4:12pm
CERT
dw3xo9ji3matkf9t5l
29 Mar 19
Certification of approval for exchange listing
9:02am
IRAN
3i3nokjgij0d ifml
15 Mar 19
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
4:25pm
SD
zeg vgwbo
30 May 18
Conflict minerals disclosure
2:21pm